Mycobacterium tuberculosis: Bacterial Fitness within the Host Macrophage
- PMID: 30848232
- PMCID: PMC6459685
- DOI: 10.1128/microbiolspec.BAI-0001-2019
Mycobacterium tuberculosis: Bacterial Fitness within the Host Macrophage
Abstract
Mycobacterium tuberculosis has evolved to become the single greatest cause of death from an infectious agent. The pathogen spends most of its infection cycle in its human host within a phagocyte. The bacterium has evolved to block the normal maturation and acidification of its phagosome and resides in a vacuole contiguous with the early endosomal network. Cytokine-mediated activation of the host cell can overcome this blockage, and an array of antimicrobial responses can limit its survival. The survival of M. tuberculosis in its host cell is fueled predominantly by fatty acids and cholesterol. The ability of M. tuberculosis to degrade sterols is an unusual metabolic characteristic that was likely retained from a saprophytic ancestor. Recent results with fluorescent M. tuberculosis reporter strains demonstrate that bacterial survival differs with the host macrophage population. Tissue-resident alveolar macrophages, which are biased towards an alternatively activated, M2-like phenotype, are more permissive to bacterial growth than monocyte-derived, inflammatory, M1-like interstitial macrophages. The differential growth of the bacterium in these different phagocyte populations appears to be linked to host cell metabolism.
Figures






Similar articles
-
Macrophage defense mechanisms against intracellular bacteria.Immunol Rev. 2015 Mar;264(1):182-203. doi: 10.1111/imr.12266. Immunol Rev. 2015. PMID: 25703560 Free PMC article. Review.
-
Trans-species communication in the Mycobacterium tuberculosis-infected macrophage.Immunol Rev. 2015 Mar;264(1):233-48. doi: 10.1111/imr.12254. Immunol Rev. 2015. PMID: 25703563 Free PMC article. Review.
-
Importance of phagosomal functionality for growth restriction of Mycobacterium tuberculosis in primary human macrophages.J Innate Immun. 2011;3(5):508-18. doi: 10.1159/000325297. Epub 2011 May 11. J Innate Immun. 2011. PMID: 21576918 Free PMC article.
-
The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.Elife. 2020 May 4;9:e55692. doi: 10.7554/eLife.55692. Elife. 2020. PMID: 32369020 Free PMC article.
-
Mycobacterium tuberculosis metabolism and host interaction: mysteries and paradoxes.Curr Top Microbiol Immunol. 2013;374:163-88. doi: 10.1007/82_2012_299. Curr Top Microbiol Immunol. 2013. PMID: 23242856 Review.
Cited by
-
Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease.Front Immunol. 2023 Sep 27;14:1250198. doi: 10.3389/fimmu.2023.1250198. eCollection 2023. Front Immunol. 2023. PMID: 37841265 Free PMC article. Review.
-
Nutritional Deficiencies and Management in Tuberculosis: Pharmacotherapeutic and Clinical Implications.Nutrients. 2025 May 30;17(11):1878. doi: 10.3390/nu17111878. Nutrients. 2025. PMID: 40507146 Free PMC article. Review.
-
Nuclear Factor κB Signaling Deficiency in CD11c-Expressing Phagocytes Mediates Early Inflammatory Responses and Enhances Mycobacterium tuberculosis Control.J Infect Dis. 2024 Aug 16;230(2):336-345. doi: 10.1093/infdis/jiae060. J Infect Dis. 2024. PMID: 38324907 Free PMC article.
-
The roles of microRNAs played in lung diseases via regulating cell apoptosis.Mol Cell Biochem. 2021 Dec;476(12):4265-4275. doi: 10.1007/s11010-021-04242-x. Epub 2021 Aug 16. Mol Cell Biochem. 2021. PMID: 34398353 Review.
-
Synthesis and anti-mycobacterial activity of novel medium-chain β-lactone derivatives: a multi-target strategy to combat Mycobacterium abscessus.RSC Med Chem. 2025 Apr 25;16(7):3251-3272. doi: 10.1039/d5md00102a. eCollection 2025 Jul 16. RSC Med Chem. 2025. PMID: 40417425 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical